This volume presents reports from recent scientific meetings on
topics in emerging fields: (1) Diabetes and Oral Disease:
Implications for Health Professionals; (2) The New York Stem Cell
Foundation: Sixth Annual Translational Stem Cell Research
Conference; and (3) Chronic Inflammatory and Neuropathic
Pain."Diabetes and Oral Disease: Implications for Health
Professionals" was a one-day conference convened by the Columbia
University College of Dental Medicine, the Columbia University
College of Physicians and Surgeons, and the New York Academy of
Sciences on May 4, 2011 at The New York Academy of Sciences in New
York City. The program included an examination of the bidirectional
relationship between oral disease and diabetes and the
inter-professional working relationships for the care of people who
have diabetes. The overall goal of the conference was to promote
discussion among the healthcare professions who treat people with
diabetes, encourage improved communication and collaboration among
them and ultimately, improve patient management of the oral and
overall effects of diabetes. Attracting over 150 members of the
medical and dental professions from eight different countries, the
conference included speakers from academia and government and was
divided into four sessions. This report summarizes the scientific
presentations of the event.
The New York Stem Cell Foundation's "Sixth Annual Translational
Stem Cell Research Conference" convened on October 11-12, 2011 at
The Rockefeller University in New York City. Over 450 scientists,
patient advocates, and stem cell research supporters from 14
countries registered for the conference. In addition to poster and
platform presentations, the conference featured panels entitled
"Road to the Clinic" and "The Future of Regenerative
Medicine."Sponsored by The New York Academy of Sciences, MedImmune,
and Grunenthal Gmbh, "Chronic Inflammatory and Neuropathic Pain"
was a two-day conference June 2-3, 2011 at the New York Academy of
Sciences in New York City. Leading and emerging investigators
studying the pathophysiological mechanisms underlying neuropathic
and chronic pain, and experts in the clinical development of pain
therapies came together at this forum to address novel issues,
current challenges, and future directions of basic research in pain
and pre-clinical and clinical development of new therapies for
chronic pain. Presentations examined recent therapeutic
breakthroughs based on small molecules; the emerging role of
biologics as potential new therapies; and current challenges and
potential solutions for improved translation of new pain therapies
following early target identification, pre-clinical modeling, and
clinical development.
NOTE: "Annals" volumes are available for sale as individual
books or as a journal. For information on institutional journal
subscriptions, please visit http:
//ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences
directly to place your order (www.nyas.org). Members of the New
York Academy of Science receive full-text access to "Annals" online
and discounts on print volumes. Please visit http:
//www.nyas.org/MemberCenter/Join.aspx for more information about
becoming a member.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!